Potential Benefits of Adding Alendronate, Celecoxib, Itraconazole, Ramelteon, and Simvastatin to Endometrial Cancer Treatment: The EC5 Regimen.

Curr Issues Mol Biol · 2025 · PMC11941490 · PMID 40136407

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

did not reach statistical significanceno p-value reported

A slight trend toward a longer survival was only seen in patients <40 and >60 years old, and did not reach statistical significance. 2.2.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.